Parity and thyroid cancer risk: A meta-analysis of epidemiological studies

Cancer Medicine

Volumn 5, Issue 4, 2016, Pages 739-752

  Zhu, Jingjing ^a,c   Zhu, Xiao ^d   Tu, Chao ^e   Li, Yuan Yuan ^f   Qian, Ke Qing ^e   Jiang, Cheng ^g   Feng, Tong Bao ^e   Li, Changwei ^h   Liu, Guang Jian ^b   Wu, Lang ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

^f XUZHOU MEDICAL UNIVERSITY   (China)

^g THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^h TULANE UNIVERSITY   (United States)

Author keywords

Epidemiology; Meta analysis; Parity; Risk; Thyroid cancer

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; HUMAN; LINEAR SYSTEM; META ANALYSIS (TOPIC); METHODOLOGY; NONLINEAR SYSTEM; NULLIPARA; PARITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW; THYROID CANCER; FEMALE; META ANALYSIS; ODDS RATIO; PREGNANCY; REPRODUCTIVE HISTORY; RISK; THYROID NEOPLASMS;

CASE-CONTROL STUDIES; FEMALE; HUMANS; ODDS RATIO; PARITY; PREGNANCY; REPRODUCTIVE HISTORY; RISK; THYROID NEOPLASMS;

EID: 85006202923     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.604     Document Type: Article

References (64)

1. Wartofsky, L. 2010. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens). 9:103-108.
2. Siegel, R. L., K. D. Miller, and A. Jemal . 2015. Cancer statistics, 2015. CA Cancer J. Clin. 65:5-29. doi: 10.3322/caac.21254.
3. Sakorafas, G. H., H. Friess, and G. Peros . 2008. The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy. Endocr. Relat. Cancer 15:871-884. doi: 10.1677/ERC-08-0098.
4. Musholt, T. J., P. B. Musholt, T. Petrich, G. Oetting, W. H. Knapp, and J. Klempnauer . 2000. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J. Surg. 24:1409-1417.
5. Pacini, F., M. G. Castagna, L. Brilli, G. Pentheroudakis, and E. G. W. Group . 2012. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23(Suppl 7):vii110-vii119. doi:10.1093/annonc/mds230.
6. Peterson, E., P. De, and R. Nuttall . 2012. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS ONE 7:e29177. doi: 10.1371/journal.pone.0029177.
7. Dal Maso, L., C. Bosetti, C. La Vecchia, and S. Franceschi . 2009. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20:75-86.
8. Jing, Z., X. Hou, Y. Liu, S. Yan, R. Wang, S. Zhao, et al. 2015. Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies. Int. J. Cancer 137:1484-1490. doi: 10.1002/ijc.29487.
9. Yeo, Y., S. H. Ma, Y. Hwang, P. L. Horn-Ross, A. Hsing, K. E. Lee, et al. 2014. Diabetes mellitus and risk of thyroid cancer: a meta-analysis. PLoS ONE 9:e98135. doi: 10.1371/journal.pone.0098135.
10. Zhao, Z. G., X. G. Guo, C. X. Ba, W. Wang, Y. Y. Yang, J. Wang, et al. 2012. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J. Int. Med. Res. 40:2041-2050.
11. Kitahara, C. M., M. S. Linet, L. E. Beane Freeman, D. P. Check, T. R. Church, Y. Park, et al. 2012. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control 23:1615-1624. doi: 10.1007/s10552-012-0039-2.
12. Sakoda, L. C., and P. L. Horn-Ross . 2002. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol. Biomark. Prev. 11:51-57.
13. Wu, L., and J. Zhu . 2015. Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies. Hum. Reprod. 30:2234-2240. doi: 10.1093/humrep/dev160.
14. McTiernan, A. M., N. S. Weiss, and J. R. Daling . 1984. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am. J. Epidemiol. 120:423-435.
15. Truong, T., L. Orsi, D. Dubourdieu, Y. Rougier, D. Hemon, and P. Guenel . 2005. Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am. J. Epidemiol. 161:1056-1065. doi: 10.1093/aje/kwi136.
16. Braganza, M. Z., A. B. de Gonzalez, S. J. Schonfeld, N. Wentzensen, A. V. Brenner, and C. M. Kitahara . 2014. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev. Res. (Phila.) 7:418-425. doi: 10.1158/1940-6207.CAPR-13-0367.
17. Pham, T. M., Y. Fujino, H. Mikami, N. Okamoto, Y. Hoshiyama, A. Tamakoshi, et al. 2009. Reproductive and menstrual factors and thyroid cancer among Japanese women: the Japan Collaborative Cohort Study. J Womens Health (Larchmt). 18:331-335. doi: 10.1089/jwh.2008.1038.
18. Wong, E. Y., R. Ray, D. L. Gao, K. J. Wernli, W. Li, E. D. Fitzgibbons, et al. 2006. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai. China. Int Arch Occup Environ Health. 79:251-258. doi: 10.1007/s00420-005-0036-9.
19. Preston-Martin, S., F. Jin, M. J. Duda, and W. J. Mack . 1993. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 4:431-440.
20. Galanti, M. R., M. Lambe, A. Ekbom, P. Sparen, and B. Pettersson . 1995. Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort. Cancer Causes Control 6:37-44.
21. Schonfeld, S. J., E. Ron, C. M. Kitahara, A. Brenner, Y. Park, A. J. Sigurdson, et al. 2011. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol. 35:e85-e90. doi: 10.1016/j.canep.2011.05.009.
22. Negri, E., L. Dal Maso, E. Ron, C. La Vecchia, S. D. Mark, S. Preston-Martin, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10:143-155.
23. Stroup, D. F., J. A. Berlin, S. C. Morton, I. Olkin, G. D. Williamson, D. Rennie, et al. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012.
24. Wu, L., Z. Wang, J. Zhu, A. Murad, L. Prokop, and M. Murad . 2015. Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis. Nutr. Rev. 73:409-425. doi: 10.1093/nutrit/nuv006.
25. Wu, L., J. Zhu, L. Prokop, and M. Murad . 2015. Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies. Sci. Rep. 5:10147.
26. Wu, Q. J., L. Wu, L. Q. Zheng, X. Xu, C. Ji, and T. T. Gong . 2015. Consumption of fruit and vegetables reduces risk of pancreatic cancer: evidence from epidemiological studies. Eur. J. Cancer Prev. Epub 2015 Jun 11. doi: 10.1097/CEJ.0000000000000171.
27. Wang, Y. Z., Q. J. Wu, J. Zhu, and L. Wu . 2015. Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies. Cancer Causes Control 26:1307-1314. doi: 10.1007/s10552-015-0625-1.
28. Guan, H. B., L. Wu, Q. J. Wu, J. Zhu, and T. Gong . 2014. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies. PLoS ONE 9:e92738. doi: 10.1371/journal.pone.0092738.
29. Wu, Q. J., C. Tu, Y. Y. Li, J. Zhu, K. Q. Qian, W. J. Li, et al. 2015. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget. Epub 2015 Oct 12. doi: 10.18632/oncotarget.5557.
30. Wells, G. A., B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed May 15 2015).
31. Higgins, J. P., S. G. Thompson, J. J. Deeks, and D. G. Altman . 2003. Measuring inconsistency in meta-analyses. BMJ 327:557-560. doi: 10.1136/bmj.327.7414.557.
32. Higgins, J. P., and S. G. Thompson . 2002. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21:1539-1558. doi: 10.1002/sim.1186.
33. Wu, Q. J., Y. Y. Li, C. Tu, J. Zhu, K. Q. Qian, T. B. Feng, et al. 2015. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci. Rep. 5:14243. doi: 10.1038/srep14243.
34. DerSimonian, R., and N. Laird . 1986. Meta-analysis in clinical trials. Control. Clin. Trials 7:177-188.
35. Greenland, S., and M. P. Longnecker . 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 135:1301-1309.
36. Orsini, N., R. Li, A. Wolk, P. Khudyakov, and D. Spiegelman . 2012. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am. J. Epidemiol. 175:66-73. doi: 10.1093/aje/kwr265.
37. Liu, Q., N. R. Cook, A. Bergstrom, and C. C. Hsieh . 2009. A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose-response data. Comput. Stat. Data Anal. 53:4157-4167.
38. Begg, C. B., and M. Mazumdar . 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
39. Rossing, M. A., L. F. Voigt, K. G. Wicklund, and J. R. Daling . 2000. Reproductive factors and risk of papillary thyroid cancer in women. Am. J. Epidemiol. 151:765-772.
40. Egger, M., G. Davey Smith, M. Schneider, and C. Minder . 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
41. Memon, A., M. Darif, K. Al-Saleh, and A. Suresh . 2002. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int. J. Cancer 97:82-89.
42. Zivaljevic, V., H. Vlajinac, R. Jankovic, J. Marinkovic, R. Dzodic, S. Sipeti Grujii, et al. 2003. Case-control study of female thyroid cancer-menstrual, reproductive and hormonal factors. Eur. J. Cancer Prev. 12:63-66. doi: 10.1097/01.cej.0000051107.66188.86.
43. Xhaard, C., C. Rubino, E. Clero, S. Maillard, Y. Ren, F. Borson-Chazot, et al. 2014. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in france: a population-based case-control study. Am. J. Epidemiol. 180:1007-1017. doi: 10.1093/aje/kwu220.
44. Akslen, L. A., S. Nilssen, and G. Kvale . 1992. Reproductive factors and risk of thyroid cancer. A prospective study of 63, 090 women from Norway. Br. J. Cancer 65:772-774.
45. Navarro Silvera, S. A., A. B. Miller, and T. E. Rohan . 2005. Risk factors for thyroid cancer: a prospective cohort study. Int. J. Cancer 116:433-438. doi: 10.1002/ijc.21079.
46. Kabat, G. C., M. Y. Kim, J. Wactawski-Wende, D. Lane, S. Wassertheil-Smoller, and T. E. Rohan . 2012. Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control 23:2031-2040. doi: 10.1007/s10552-012-0084-x.
47. Zamora-Ros, R., S. Rinaldi, C. Biessy, A. Tjonneland, J. Halkjaer, A. Fournier, et al. 2015. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. Int. J. Cancer 5:1218-1227. doi: 10.1002/ijc.29067.
48. Brindel, P., F. Doyon, F. Rachedi, J. L. Boissin, J. Sebbag, L. Shan, et al. 2008. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am. J. Epidemiol. 167:219-229. doi: 10.1093/aje/kwm288.
49. Hannibal, C. G., A. Jensen, H. Sharif, and S. K. Kjaer . 2008. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum. Reprod. 23:451-456. doi: 10.1093/humrep/dem381.
50. Kalezic, N. K., V. R. Zivaljevic, N. A. Slijepcevic, I. R. Paunovic, A. D. Diklic, and S. B. Sipetic . 2013. Risk factors for sporadic medullary thyroid carcinoma. Eur. J. Cancer Prev. 22:262-267. doi: 10.1097/CEJ.0b013e3283592c78.
51. Horn-Ross, P. L., A. J. Canchola, H. Ma, P. Reynolds, and L. Bernstein . 2011. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol. Biomark. Prev. 20:1751-1759. doi: 10.1158/1055-9965.EPI-11-0381.
52. Przybylik-Mazurek, E., A. Hubalewska-Dydejczyk, A. Fedorowicz, and D. Pach . 2012. Factors connected with the female sex seem to play an important role in differentiated thyroid cancer. Gynecol. Endocrinol. 28:150-155. doi: 10.3109/09513590.2011.563909.
53. Lee, S. M., and K. H. Kwak . 2010. Risk factors and a predictive model for thyroid cancer in Korean women. Cancer Nurs. 33:310-319. doi: 10.1097/NCC.0b013e3181cd2844.
54. Takezaki, T., K. Hirose, M. Inoue, N. Hamajima, T. Kuroishi, S. Nakamura, et al. 1996. Risk factors of thyroid cancer among women in Tokai, Japan. J. Epidemiol. 6:140-147.
55. Lence-Anta, J. J., C. Xhaard, R. M. Ortiz, H. Kassim, C. M. Pereda, S. Turcios, et al. 2014. Environmental, lifestyle, and anthropometric risk factors for differentiated thyroid cancer in cuba: a case-control study. Eur Thyroid J. 3:189-196. doi: 10.1159/000362928.
56. Manole, D., B. Schildknecht, B. Gosnell, E. Adams, and M. Derwahl . 2001. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J. Clin. Endocrinol. Metab. 86:1072-1077. doi: 10.1210/jcem.86.3.7283.
57. Glinoer, D., P. de Nayer, P. Bourdoux, M. Lemone, C. Robyn, A. van Steirteghem, et al. 1990. Regulation of maternal thyroid during pregnancy. J. Clin. Endocrinol. Metab. 71:276-287. doi: 10.1210/jcem-71-2-276.
58. Rajoria, S., R. Suriano, A. Shanmugam, Y. L. Wilson, S. P. Schantz, J. Geliebter, et al. 2010. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20:33-41. doi: 10.1089/thy.2009.0296.
59. Lee, M. L., G. G. Chen, A. C. Vlantis, G. M. Tse, B. C. Leung, and C. A. van Hasselt . 2005. Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J. 11:113-121.
60. Bouman, A., M. J. Heineman, and M. M. Faas . 2005. Sex hormones and the immune response in humans. Hum Reprod Update. 11:411-423. doi: 10.1093/humupd/dmi008.
61. Chen, G. G., A. C. Vlantis, Q. Zeng, and C. A. van Hasselt . 2008. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr. Cancer Drug Targets 8:367-377.
62. Cao, Y. W. Z., J. Gu, F. Hu, Y. Qi, Q. Yin, et al. 2015. Reproductive factors but not hormonal factors associated with thyroid cancer risk: a systematic review and meta-analysis. BioMed Research International. 2015:103515. doi: 10.1155/2015/103515.
63. Caini, S., B. Gibelli, D. Palli, C. Saieva, M. Ruscica, and S. Gandini . 2015. Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies. Cancer Causes Control 26:511-518. doi: 10.1007/s10552-015-0546-z.
64. Zhou, Y. Q., Z. Zhou, M. F. Qian, T. Gong, and J. D. Wang . 2015. Association of thyroid carcinoma with pregnancy: a meta-analysis. Mol Clin Oncol. 3:341-346. doi: 10.3892/mco.2014.472.